Syndax Pharmaceuticals, Inc. (SNDX) Financials

SNDX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 472.7 million 431.0 million
Dec. 31, 2025 529.7 million 465.1 million
Sept. 30, 2025 551.8 million 436.4 million
June 30, 2025 596.1 million 438.7 million

SNDX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -50.3 million 12.1 million
Dec. 31, 2025 -69.5 million 11.3 million
Sept. 30, 2025 -70.7 million 12.1 million
June 30, 2025 -87.8 million 13.8 million

SNDX Net Income

No data available :(

SNDX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 352.1 million 344.0 million 1.4 million
Dec. 31, 2025 394.1 million 345.0 million 1.1 million
Sept. 30, 2025 454.2 million 321.0 million 1.5 million
June 30, 2025 468.7 million - 1.7 million

SNDX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 86.6 million
Dec. 31, 2025 86.6 million
Sept. 30, 2025 86.6 million
June 30, 2025 86.3 million

SNDX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 58.8 million 37.6 million -
Dec. 31, 2025 56000 78.6 million 49.9 million -
Sept. 30, 2025 131000 56.3 million 44.9 million -
June 30, 2025 - 62.2 million 43.8 million -

SNDX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 64.9 million 2.6 million
Dec. 31, 2025 68.5 million -1.6 million
Sept. 30, 2025 45.9 million 2.1 million
June 30, 2025 38.0 million 1.3 million

SNDX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

SNDX

Price: $18.48

52 week price:
8.59
25.59

Earnings Per Share: -2.79 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 44479

Ebitda: -15.3 million

Market Capitalization: 1.6 billion

Links: